search
Back to results

Study in Patients With Asthma

Primary Purpose

Asthma

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Formoterol Fumarate
Sponsored by
Dey
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring Asthma, Formoterol, Fumarate

Eligibility Criteria

5 Years - 70 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patients with a history of asthma Exclusion Criteria: Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization History of smoking Debilitating systemic and/or life-threatening diseases.

Sites / Locations

  • Research Site
  • Research Site
  • Research Site

Outcomes

Primary Outcome Measures

The primary outcome variable is the measure of lung function.

Secondary Outcome Measures

Secondary outcomes include change in lung function, as well as in vital signs.
Physical exams, AE reporting, etc.

Full Information

First Posted
September 13, 2005
Last Updated
November 10, 2010
Sponsor
Dey
search

1. Study Identification

Unique Protocol Identification Number
NCT00215397
Brief Title
Study in Patients With Asthma
Study Type
Interventional

2. Study Status

Record Verification Date
February 2008
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
February 2003 (Actual)
Study Completion Date
December 2005 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
Dey

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective in the treatment of asthma compared to the control drug.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Asthma, Formoterol, Fumarate

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Crossover Assignment
Masking
Double
Allocation
Randomized
Enrollment
16 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Formoterol Fumarate
Primary Outcome Measure Information:
Title
The primary outcome variable is the measure of lung function.
Secondary Outcome Measure Information:
Title
Secondary outcomes include change in lung function, as well as in vital signs.
Title
Physical exams, AE reporting, etc.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with a history of asthma Exclusion Criteria: Current asthma exacerbation or recent asthma exacerbation, requiring hospitalization History of smoking Debilitating systemic and/or life-threatening diseases.
Facility Information:
Facility Name
Research Site
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States
Facility Name
Research Site
City
Denver
State/Province
Colorado
ZIP/Postal Code
80206
Country
United States
Facility Name
Research Site
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Study in Patients With Asthma

We'll reach out to this number within 24 hrs